ImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an ...
This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...